Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Pirfenidone – Treatment for Idiopathic Pulmonary Fibrosis

IPF mainly involves cellular proliferation and enhanced biosynthesis which is caused by cytokine growth factors.



Close
Close
Close

Go Top